Cannabis Law Report

DECEMBER 9, 2021

DUBLIN–(BUSINESS WIRE)–The “Global Hemp Derivative Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type (Hemp CBD Oil, Seed Oil, Hemp Fiber, and Others) and Application” report has been added to ResearchAndMarkets.com’s offering. Overview – Impact of COVID-19.

Oil 52

Oil Hemp CBD Research and Development 52

Veriheal

DECEMBER 16, 2021

have increased during the COVID-19 pandemic and have climbed almost 30% in the last year. The world may be focused on COVID-19 at the moment, but the opioid crisis silently continues to ravage society. ” According to CBS News, overdose deaths in the U.S. The Opioid Crisis Rages On.

Recreational 98

Recreational Dispensary Cannabis Treatment 98

Cannabis Law Report

DECEMBER 22, 2021

COVID-19 VACCINE REQUIREMENT: For candidates seeking initial City employment, in accordance with Los Angeles City Ordinance 187134, information regarding COVID-19 vaccination requirements as conditions of employment may be found at: [link]. Health insurance. Health savings account. Life insurance. Paid time off.

Research and Development 52

Research and Development Advocacy Programs Cannabis 52

Cannabis Law Report

DECEMBER 1, 2021

Amid the COVID-19 crisis, the global market for Denim Jeans estimated at US$63.5 Impact of COVID-19 and a Looming Global Recession. COVID-19 Industry Impact Trends. Global Textile and Apparel Industry and the Impact of COVID-19. Billion by 2027, growing at a CAGR of 4.7% Raymond Group.

Consumption 52

Consumption Retail Business Environment 52

Cannabis Law Report

DECEMBER 3, 2021

Leveraging its deep expertise in nucleic acid-based technologies, the Company has also established safeCircle™, a pooled COVID-19 testing program that is grounded in the Company’s EUA-authorized Linea™ COVID-19 Assay Kit.

Therapy 52

Therapy Supply Chain Pharmaceutical Events 52

Cannabis Law Report

DECEMBER 23, 2021

million “Cannabis Emergency Relief Fund” (CERF), allocated from the city’s cannabis tax revenue, for local cannabis businesses impacted by the COVID-19 pandemic and the rising rates of robberies and vandalism at cannabis businesses in Portland. The Portland City Council two weeks ago announced a $1.33 Funding Eligibility.

Programs 52

Programs Business Cannabis Education 52

Cannabis Law Report

DECEMBER 4, 2021

States and cities collected $350 billion from the COVID-19 stimulus package to spend on everything from subsides for low income renters to pay increases for teachers. “We’ll have some long lasting consequences of the pandemic and you’ll need to make money up somewhere,” said Mikhail Foux, Barclays head of municipal strategy.

Packaging 52

Packaging Banking Collective Recreational 52

Cannabis Law Report

DECEMBER 28, 2021

19 – Florida court blocks Make It Legal adult-use campaign for 2022. 19 – Brooklyn Net Kevin Durant partners with Weedmaps. 19 – Dr. Sanjay Gupta hosts “Weed 6” about cannabis and autism on CNN. Jast hope that Covid gradually fades and business can get back to usual. DEATH: Eddy Lepp.

THC 52

THC Cannabis Banking Legalization 52

Cannabis Law Report

DECEMBER 8, 2021

Strong free cash flow 2 of $302 million was generated, a 19% increase compared to the prior-year period. Net sales in the Travel Retail 3 channel increased 38% (+64% underlying) primarily due to a favorable prior-year comparison, which was significantly impacted by COVID-19 related travel bans and restrictions. 19. . . .

Supply Chain 52

Supply Chain Business Retail Policy 52

Cannabis Law Report

DECEMBER 17, 2021

DUBLIN–(BUSINESS WIRE)–The “Cannabis Testing Services Market Research Report by Type, End-user, and Region – Global Forecast to 2026 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. million in 2020, is expected to reach USD 373.58 million by 2026.

Research and Development 52

Research and Development Business Cannabis Access 52

Cannabis Law Report

DECEMBER 1, 2021

MYMD-1 is also showing promise in pre-clinical studies as a potential treatment for post- COVID-19 complications and as an anti-fibrotic and anti-proliferation therapeutic. MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases and COVID-19- associated depression.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

DECEMBER 14, 2021

What impact does the current COVID-19 pandemic have on the direct-to-consumer pet food market at various levels in the value chain? Impact of COVID-19 on the Direct-to-Consumer Pet Food Market. What are the major factors impacting the growth of this market at a global and regional level? Opportunities. Key Players.

Pets 52

Pets Food Digestion Conditions 52

Cannabis Law Report

DECEMBER 7, 2021

The company was recently recognized as a 2021 Microsoft US Partner Award winner for its innovative SaaS solutions to help governments respond to the COVID-19 pandemic, and was named as one of the Largest East Bay Tech Employers by San Francisco Business Times.

Patients 52

Patients Business Compliance Compliance 52

Veriheal

DECEMBER 21, 2021

Since the country is facing an uphill financial battle—mainly due to economic disruptions caused by the COVID-19 pandemic—legalization couldn’t have come at a better time. According to Aoun, Parliament’s legalization effort was “really driven by economic motives, nothing else.”

Law 98

Law Education History Research and Development 98

Cannabis Law Report

DECEMBER 15, 2021

Unfortunately, though, I believe this number is understated and the real number is way higher , for 3 reasons: This is a pre COVID-19 figure. We all regularly quote the shocking “1 billion people suffer worldwide from mental health issues” statistic.

Research and Development 52

Research and Development Data History Patients 52

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)–The “Cannabis Testing Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Product, Type, End User, and Portability and Geography” report has been added to ResearchAndMarkets.com’s offering. According to the study, the market is expected to reach US$ 2,960.2

Research and Development 52

Research and Development Terpenes Business Education 52

Cannabis Law Report

DECEMBER 31, 2021

Numerous risks and uncertainties could cause the actual events and results to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements, including, but not limited to: anticipated strategic, operational and competitive benefits may not be realized; events or series of events, including in connection (..)

Dispensary 52

Dispensary Events Cultivation Agriculture 52

Cannabis Law Report

DECEMBER 18, 2021

All Office of Cannabis Management (OCM) employees are required to be tested weekly for COVID-19 unless they are fully vaccinated. Additional Comments. Work location and telecommuting opportunities to be discussed at interview. Employees who are vaccinated must provide proof of vaccine status through a secure online portal.

Legislation 52

Legislation Policy Programs Cannabis 52

Veriheal

DECEMBER 20, 2021

After delays caused by COVID-19 over the past couple of years, CSU currently has 15 projects related to cannabinoids up and running, including research being conducted by the psychology department that is exploring the effects of cannabinoids on alcohol addiction and treatment.

Cannabinoids 40

Cannabinoids THC CBD Agriculture 40

Cannabis Law Report

DECEMBER 17, 2021

Such forward-looking statements are subject to various risks and uncertainties, including the ability of the Company to enter into a definitive agreement to acquire Cova on satisfactory terms or at all, the legal and regulatory requirements and risks of acquiring a company that serves the cannabis industry, the risk that the acquisition of Cova may (..)

Compliance 52

Compliance Compliance Dispensary Seed-To-Sale 52

Cannabis Law Report

DECEMBER 7, 2021

Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated.

Programs 52

Programs Policy Cannabis Conditions 52

Cannabis Law Report

DECEMBER 14, 2021

IGC incorporates by reference the human trial disclosures and Risk Factors identified in its Annual Reports on Form 10-K filed with the SEC on June 14, 2021, and Quarterly Report on Form 10-Q, filed with the SEC on August 11, 2021, and October 29, 2021 as if fully incorporated and restated herein.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Cannabis Law Report

DECEMBER 8, 2021

These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors, including the potential impact of the recent COVID-19 pandemic and the potential impact of sustained social distancing efforts, on the Company’s operations, clinical development plans and timelines, which may (..)

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Cannabis Law Report

DECEMBER 20, 2021

These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors, including the potential impact of the recent COVID-19 pandemic and the potential impact of sustained social distancing efforts, on the Company’s operations, clinical development plans and timelines, which may (..)

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

DECEMBER 10, 2021

DUBLIN–(BUSINESS WIRE)–The “Vertical Farming Market with COVID-19 Impact Analysis by Growth Mechanism (Hydroponics, Aeroponics, Aquaponics), Structure (Building-based vertical farm and Shipping container-based vertical farm), Crop Type, Offering, & Region – Global Forecast to 2026” report has been added to ResearchAndMarkets.com’s (..)

Hydroponic 52

Hydroponic Supply Chain Agriculture Data 52

Cannabis Law Report

DECEMBER 14, 2021

The factors that could cause the company’s actual results to vary materially from those anticipated or expressed in any forward-looking statement include: (1) impacts of, and associated responses to, the COVID-19 pandemic on our business, suppliers, customers, consumers and employees; (2) the company’s ability to execute on and realize the expected (..)

Supply Chain 52

Supply Chain Food Business Programs 52

Cannabis Law Report

DECEMBER 3, 2021

Such risks and uncertainties include, among others, the risk that the FDA will require additional clinical trials or data; any delays in review of the NDA submission by the FDA for any reason, including the COVID-19 pandemic; the timing of regulatory filings for our product candidates; the potential that regulatory authorities, including the FDA and (..)

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

DECEMBER 2, 2021

IGC incorporates by reference the human trial disclosures and Risk Factors identified in its Annual Reports on Form 10-K filed with the SEC on June 14, 2021, and Quarterly Report on Form 10-Q, filed with the SEC on August 11, 2021, and October 29, 2021 as if fully incorporated and restated herein.

Clinical Trials 52

Clinical Trials Data Patients THC 52

Cannabis Law Report

DECEMBER 15, 2021

Leveraging its deep expertise in nucleic acid-based technologies, the Company has also established safeCircle™, a high-throughput turnkey solution for population-scale COVID-19 testing.

Supply Chain 52

Supply Chain Therapy Research and Development Events 52

Cannabis Law Report

DECEMBER 6, 2021

Leveraging its deep expertise in nucleic acid-based technologies, the Company has also established safeCircle™, a high-throughput turnkey solution for population-scale COVID-19 testing.

Supply Chain 52

Supply Chain Therapy Research and Development Data 52

Cannabis Law Report

DECEMBER 21, 2021

To quantify why digital transformation is celebrated by customers and demanded by businesses, consumer spending trends reported during COVID-19 now include: 18-23% growth in 2021 ($1.09-$1.13 Software and apps are lifelines for connecting industries with individuals.

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

DECEMBER 2, 2021

An amendment was proposed to suspend the in-person training requirement for the duration of the COVID-19 health emergency. At least 50% of the core training hours not conducted in-person would need to be completed through online synchronous learning (i.e., interactive, real-time online training with an instructor and fellow students).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

DECEMBER 1, 2021

All statements from The OLB Group, Inc.

CBD 52

CBD eCommerce Business Data 52

Cannabis Law Report

DECEMBER 28, 2021

These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors, including the potential impact of the recent COVID-19 pandemic and the potential impact of sustained social distancing efforts, on the Company’s operations, clinical development plans and timelines, which may (..)

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

DECEMBER 14, 2021

Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond HempFusion’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements.

Supply Chain 52

Supply Chain Retail Topical Research and Development 52

Cannabis Law Report

DECEMBER 9, 2021

Such factors, among other things, include: regulatory and other approvals or consents; fluctuations in general macroeconomic conditions; fluctuations in securities markets; the impact of the COVID-19 pandemic; the ability of the Company and Pineapple Express to successfully achieve its business objectives and political and social uncertainties.

Retail 52

Retail Media Collective Conditions 52